GH Research (GHRS) Other financing activities (2020 - 2023)

GH Research's (GHRS) quarterly Other financing activities came in at -$8.2 million in Q2 2023, down 52.37% year-on-year from -$17.2 million in Q2 2022, and down 107.79% quarter-over-quarter from $105.1 million in Q1 2023.

GH Research (GHRS) Other financing activities (2020 - 2023) Analysis & Trends

GH Research's Other financing activities history runs 4 years deep, the most recent figure standing at -$8.2 million for Q2 2023.

  • On a quarterly basis, Other financing activities fell 52.37% year-over-year to -$8.2 million in Q2 2023; TTM through Jun 2023 was $108.3 million, a 59.19% decrease from a year earlier, with the FY2022 full-year figure at $276.8 million, down 10.49% from the prior year.
  • Other financing activities declined to -$8.2 million in Q2 2023 per GHRS's latest filing, from $105.1 million in the prior quarter.
  • Across five years, Other financing activities topped out at $304.6 million in Q2 2021 and bottomed at -$8.4 million in Q3 2022.
  • The 4-year median for Other financing activities is $4.9 million (2020), against an average of $68.8 million.
  • Biggest YoY gain for Other financing activities was 5816.74% in 2022; the steepest drop was 101.76% in 2022.
  • Year by year, Other financing activities stood at $5.2 million in 2020, then soared by 5795.57% to $304.6 million in 2021, then tumbled by 93.49% to $19.8 million in 2022, then plunged by 141.27% to -$8.2 million in 2023.
  • Per Business Quant, the three latest GHRS Other financing activities figures stand at -$8.2 million (Q2 2023), $105.1 million (Q1 2023), and $19.8 million (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 GH Research 1.65 Bn 1.65 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -8.19 Mn
Jun 30, 2023 -8.19 Mn
Mar 31, 2023 105.08 Mn
Mar 31, 2023 105.08 Mn
Dec 31, 2022 19.84 Mn
Dec 31, 2022 19.84 Mn
Sep 30, 2022 -8.44 Mn
Sep 30, 2022 -8.44 Mn
Jun 30, 2022 -5.37 Mn
Jun 30, 2022 -5.37 Mn
Mar 31, 2022 270.75 Mn
Mar 31, 2022 270.75 Mn
Jun 30, 2021 304.62 Mn
Jun 30, 2021 304.62 Mn
Mar 31, 2021 4.58 Mn
Mar 31, 2021 4.58 Mn
Dec 31, 2020 5.17 Mn
Dec 31, 2020 5.17 Mn
Sep 30, 2020 -51,000.00
Sep 30, 2020 -51,000.00